These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 29410)

  • 1. [Effectiveness of prophylactic and antirecurrence courses of prescribed chemical preparations for persons in the II and III groups of the dispensary registration of tuberculosis].
    Levin VR; Gorbunova LV; Glikman FZ
    Zdravookhr Kirg; 1978; (4):46-7. PubMed ID: 29410
    [No Abstract]   [Full Text] [Related]  

  • 2. [Chemoprophylaxis of persons in dispensary registration group VII taking into account the risk factors of tuberculosis reactivation].
    Kovaleva SI; Grebenkina AI; Gamperis IuL; Gavrilenko AF; Kuznetsova GG
    Probl Tuberk; 1985; (10):8-11. PubMed ID: 4070209
    [No Abstract]   [Full Text] [Related]  

  • 3. [Efficacy of controlled ambulatory intermittent chemotherapy in patients with group II and III tuberculosis by dispensary classification].
    Fomicheva NI; Magaletskiĭ IF; Danchenko LI; Simkina SP
    Probl Tuberk; 1983 Feb; (2):68-9. PubMed ID: 6844334
    [No Abstract]   [Full Text] [Related]  

  • 4. [Effectiveness of the intermittent ambulatory treatment of group-II dispensary registry patients in a rural locality].
    Berezovskiĭ BA; Marchak VV; Markovskiĭ SA; Popova II; Vasylyk VU
    Probl Tuberk; 1982 Dec; (12):29-31. PubMed ID: 7156117
    [No Abstract]   [Full Text] [Related]  

  • 5. [Comparative results of controlled and uncontrolled ambulatory treatment].
    Dosen D; Kotrosan R; Vitorović V
    Plucne Bolesti Tuberk; 1974; 26 Suppl 2():68-70. PubMed ID: 4614296
    [No Abstract]   [Full Text] [Related]  

  • 6. [Dispensary registry of patients with pulmonary tuberculosis at the present stage of long-term treatment with tuberculostatic preparations].
    Oĭfebakh MI; Levin VR; Modelevskiĭ BSh
    Probl Tuberk; 1969; 47(2):4-8. PubMed ID: 5377329
    [No Abstract]   [Full Text] [Related]  

  • 7. [Effectiveness of chemotherapy in patients with newly detected pulmonary tuberculosis and its recurrence].
    Pospelov VV; Pashkov IuN
    Probl Tuberk; 1987; (2):19-21. PubMed ID: 3554213
    [No Abstract]   [Full Text] [Related]  

  • 8. [Effectiveness of chemotherapy in newly detected destructive pulmonary tuberculosis].
    Stadnikova AV; Shevchenko VV; Kol'tsova IA
    Probl Tuberk; 1978 Jun; (6):85-6. PubMed ID: 353804
    [No Abstract]   [Full Text] [Related]  

  • 9. [Effectiveness of different methods of chemotherapy in newly detected pulmonary tuberculosis].
    Ursov IG; Kononenko VG; Borovinskaia TA; Bolganova MN; Kuzina LN
    Sov Med; 1978 Apr; (4):18-22. PubMed ID: 349707
    [No Abstract]   [Full Text] [Related]  

  • 10. [Ways of reducing the recurrences of respiratory tuberculosis and their therapeutic and economic effects].
    Kuznetsova ZA
    Probl Tuberk; 1990; (12):64-5. PubMed ID: 2084701
    [No Abstract]   [Full Text] [Related]  

  • 11. [Effectiveness of the treatment of destructive pulmonary tuberculosis].
    Liabakh PP; Mel'nik VN
    Vrach Delo; 1979 Jul; (7):61-3. PubMed ID: 382635
    [No Abstract]   [Full Text] [Related]  

  • 12. [Effectiveness of the comprehensive treatment of fibrous-cavernous pulmonary tuberculosis at a specialized hospital].
    Draganiuk KA
    Sov Med; 1978 Nov; (11):27-31. PubMed ID: 152989
    [No Abstract]   [Full Text] [Related]  

  • 13. [Characteristics of the factors that decrease the results of treating newly detected respiratory organ tuberculosis].
    Fisher IuIa; Attarova IN; Orlik EM; Oreshnikova NR
    Probl Tuberk; 1979 Mar; (3):12-5. PubMed ID: 370820
    [No Abstract]   [Full Text] [Related]  

  • 14. [Principles in the performance of chemotherapy in dispensary group VI children and adolescents].
    Ovsiankina ES; Gubkina MF; Kuz'mina IK; Stakheeva LB; Borodina NN; Zaletina EIu
    Probl Tuberk Bolezn Legk; 2007; (8):25-8. PubMed ID: 17915463
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Prolonged chemotherapy in dispensary patients with fibro-cavernous pulmonary tuberculosis].
    Khudushina TA
    Probl Tuberk; 1967; 45(6):46-51. PubMed ID: 5604889
    [No Abstract]   [Full Text] [Related]  

  • 16. [Primary chemoprevention of tuberculosis in HIV-infected patients in non-industrialized countries].
    Anglaret X; Dabis F; Batungwanayo J; Perronne C; Taelman H; Bonard D; Sylla-Koko F; Leroy V; Van de Perre P; Vildé JL; Salamon R
    Sante; 1997; 7(2):89-94. PubMed ID: 9273126
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Ambulatory chemotherapy of tuberculosis patients under rural dispensary conditions].
    Stepanenko VA; Rusnak MA; Beatova VV; Rusnak VI; Altotskaia MA
    Probl Tuberk; 1976 Jan; (l):16-7. PubMed ID: 995899
    [No Abstract]   [Full Text] [Related]  

  • 18. [Ambulatory and hospitalintermittent intravenous chemotherapy of pulmonary tuberculosis in a rural district].
    Ursov IG; Volokitin FN; Kononenko VG
    Sov Med; 1979 Apr; (4):108-10. PubMed ID: 375418
    [No Abstract]   [Full Text] [Related]  

  • 19. [Evaluation of integrated treatment of tuberculosis at 20 antituberculosis outpatient clinics].
    Ionescu C; Hreniuc R; Mihăescu T
    Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol; 1986; 35(1):75-7. PubMed ID: 3016872
    [No Abstract]   [Full Text] [Related]  

  • 20. [Treatment of patients with pulmonary tuberculosis with antitubercular preparations and levamisole].
    Feuereisl R; Papezová E
    Probl Tuberk; 1988; (3):31-3. PubMed ID: 3290887
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.